56 Works

Additional file 1 of Association between gout and the development of Parkinson’s disease: a systematic review and meta-analysis

Asra Fazlollahi, Mahdi Zahmatyar, Hossein Alizadeh, Maryam Noori, Nasrin Jafari, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Koroush Gharagozli, Ali-Asghar Kolahi & Saeid Safiri
Additional file 1: Supplementary Table 1. Search strategies for PubMed, Scopus, Web of Science, and Google scholar. Supplementary Table 2. Comorbid conditions of individuals who participated in the studies included in the meta-analysis. Supplementary Table 3. Risk of bias assessment for the included cohort studies. Supplementary Table4. Risk of bias assessments for the included case-control studies.

Additional file 1 of Psychometric properties of public trust in Covid-19 control and prevention policies questionnaire

Riaz Alaei Kalajahi, Mohammad Saadati, Saber Azami Aghdash, Ramin Rezapour, Mehdi Nouri, Naser Derakhshani & Koustuv Dalal
Supplementary Material 1

Additional file 3 of Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019

Malihe Rezaee, Zahra Esfahani, Seyed Aria Nejadghaderi, Mohsen Abbasi-Kangevari, Sahar Saeedi Moghaddam, Ali Ghanbari, Azin Ghamari, Ali Golestani, Elmira Foroutan Mehr, Ameneh Kazemi, Rosa Haghshenas, Mahsa Moradi, Farzad Kompani, Negar Rezaei & Bagher Larijani
Additional file 3: Table S1. All-age numbers and age-standardized rates of deaths, disability-adjusted-life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) attributable to lead exposure in 1990 and 2019 and overall percent change over 1990-2019 in North Africa and Middle East, by country.

Additional file 2 of Prevalence of hypertension and associated risks in hospitalized patients with COVID-19: a meta-analysis of meta-analyses with 1468 studies and 1,281,510 patients

Yousof Khairy, Deniz Naghibi, Ahmad Moosavi, Mehran Sardareh & Saber Azami-Aghdash
Additional file 2. PRISMA checklist.

Additional file 2 of The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990–2019

Hamidreza Feizi, Mahasti Alizadeh, Seyed Aria Nejadghaderi, Maryam Noori, Mark J. M. Sullman, Javad Ahmadian Heris, Ali-Asghar Kolahi, Gary S. Collins & Saeid Safiri
Additional file 2: Table S2. Prevalence of chronic obstructive pulmonary disease in 1990 and 2019 for both sexes and percentage change in age-standardised rates (ASRs) per 100,000 in the Middle East and North Africa region (generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).

Additional file 2 of The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990–2019

Hamidreza Feizi, Mahasti Alizadeh, Seyed Aria Nejadghaderi, Maryam Noori, Mark J. M. Sullman, Javad Ahmadian Heris, Ali-Asghar Kolahi, Gary S. Collins & Saeid Safiri
Additional file 2: Table S2. Prevalence of chronic obstructive pulmonary disease in 1990 and 2019 for both sexes and percentage change in age-standardised rates (ASRs) per 100,000 in the Middle East and North Africa region (generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).

Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: a systematic review and meta-analysis

Sepideh Tahsini Tekantapeh, Morteza Ghojazadeh, Ali Akbar Ghamari, Aida Mohammadi & Hassan Soleimanpour
Due to the high incidence and mortality of the worldwide COVID-19 pandemic, beneficial effects of effective antiviral and anti-inflammatory drugs used in other diseases, especially rheumatic diseases, were observed in the treatment of COVID-19. Clinical and laboratory parameters of eight included cohort studies and five Randomized Control Trials between the baricitinib group and the control group were analyzed on the first day of admission and days 7, 14, and 28 during hospitalization. According to the...

Additional file 2 of Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019

Malihe Rezaee, Zahra Esfahani, Seyed Aria Nejadghaderi, Mohsen Abbasi-Kangevari, Sahar Saeedi Moghaddam, Ali Ghanbari, Azin Ghamari, Ali Golestani, Elmira Foroutan Mehr, Ameneh Kazemi, Rosa Haghshenas, Mahsa Moradi, Farzad Kompani, Negar Rezaei & Bagher Larijani
Additional file 2. Rate of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) attributable to lead exposure in 21 countries of North Africa and Middle East region in 1990 and 2019, by sex and age.

Diagnostic accuracy of clinically applied nanoparticle-based biosensors at detecting SARS-CoV-2 RNA and surface proteins in pharyngeal swabs compared to RT-PCR as a reference test

Milad Shirvaliloo, Roghayeh Sheervalilou, Ehsan Ahmadpour, Saeid Safiri & Hossein Bannazadeh Baghi
Nanoparticle-based biosensors (NPBs) are point-of-care diagnostic platforms that can be used for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high accuracy. EBSCOhost Web, Embase, ProQuest, PubMed/MEDLINE, Scopus, Web of Science, and WHO Global Literature on Coronavirus Disease 2019 (COVID-19) were searched for relevant records published from 1 November 2019 to 30 April 2022. Records reporting original data on the accuracy of clinically applied nanoparticle-based biosensors at detecting SARS-CoV-2 RNA and surface proteins...

Additional file 1 of Association between gout and the development of Parkinson’s disease: a systematic review and meta-analysis

Asra Fazlollahi, Mahdi Zahmatyar, Hossein Alizadeh, Maryam Noori, Nasrin Jafari, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Koroush Gharagozli, Ali-Asghar Kolahi & Saeid Safiri
Additional file 1: Supplementary Table 1. Search strategies for PubMed, Scopus, Web of Science, and Google scholar. Supplementary Table 2. Comorbid conditions of individuals who participated in the studies included in the meta-analysis. Supplementary Table 3. Risk of bias assessment for the included cohort studies. Supplementary Table4. Risk of bias assessments for the included case-control studies.

Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: a systematic review and meta-analysis

Sepideh Tahsini Tekantapeh, Morteza Ghojazadeh, Ali Akbar Ghamari, Aida Mohammadi & Hassan Soleimanpour
Due to the high incidence and mortality of the worldwide COVID-19 pandemic, beneficial effects of effective antiviral and anti-inflammatory drugs used in other diseases, especially rheumatic diseases, were observed in the treatment of COVID-19. Clinical and laboratory parameters of eight included cohort studies and five Randomized Control Trials between the baricitinib group and the control group were analyzed on the first day of admission and days 7, 14, and 28 during hospitalization. According to the...

Additional file 2 of Effect of implementing a birth plan on maternal and neonatal outcomes: a randomized controlled trial

Parivash Ahmadpour, Sanaz Moosavi, Sakineh Mohammad-Alizadeh-Charandabi, Shayesteh Jahanfar & Mojgan Mirghafourvand
Additional file 2.

Additional file 2 of Prevalence of hypertension and associated risks in hospitalized patients with COVID-19: a meta-analysis of meta-analyses with 1468 studies and 1,281,510 patients

Yousof Khairy, Deniz Naghibi, Ahmad Moosavi, Mehran Sardareh & Saber Azami-Aghdash
Additional file 2. PRISMA checklist.

Additional file 3 of The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990–2019

Hamidreza Feizi, Mahasti Alizadeh, Seyed Aria Nejadghaderi, Maryam Noori, Mark J. M. Sullman, Javad Ahmadian Heris, Ali-Asghar Kolahi, Gary S. Collins & Saeid Safiri
Additional file 3: Table S3. Deaths of chronic obstructive pulmonary disease in 1990 and 2019 for both sexes and percentage change in age-standardised rates (ASRs) per 100,000 in the Middle East and North Africa region (generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).

Additional file 7 of The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990–2019

Hamidreza Feizi, Mahasti Alizadeh, Seyed Aria Nejadghaderi, Maryam Noori, Mark J. M. Sullman, Javad Ahmadian Heris, Ali-Asghar Kolahi, Gary S. Collins & Saeid Safiri
Additional file 7: Figure S3. The percentage change in the age-standardised DALYs of chronic obstructive pulmonary disease in the Middle East and North Africa region from 1990 to 2019, by sex and country. DALY = disability-adjusted-life-years (generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).

Additional file 8 of The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990–2019

Hamidreza Feizi, Mahasti Alizadeh, Seyed Aria Nejadghaderi, Maryam Noori, Mark J. M. Sullman, Javad Ahmadian Heris, Ali-Asghar Kolahi, Gary S. Collins & Saeid Safiri
Additional file 8: Figure S4. Percentage of DALYs due to chronic obstructive pulmonary disease attributable to risk factors for the Middle East and North Africa countries, by sex, in 2019. DALY = disability-adjusted-life-years (generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).

Additional file 1 of Effect of implementing a birth plan on maternal and neonatal outcomes: a randomized controlled trial

Parivash Ahmadpour, Sanaz Moosavi, Sakineh Mohammad-Alizadeh-Charandabi, Shayesteh Jahanfar & Mojgan Mirghafourvand
Additional file 1: Supplementary figure. The used questionnaires in each step of study

Additional file 1 of Why do older people not use the public health services of the integrated aging program? A multidimensional approach in a qualitative study

Amir Mohamad Moghadasi, Shima Sum & Hossein Matlabi
Additional file 1: Table 3. Why do older people not use the public health services of the integrated aging program? Reasons, Barriers and challenges (Group of older people: n=29). Table 4. Why do older people not use the public health services of the integrated aging program? Reasons, Barriers and challenges (Group of health workers: n=18).

sj-docx-1-sjs-10.1177_14574969221145774 – Supplemental material for Management of urolithiasis in pregnancy: A systematic review and meta-analysis

Hanieh Salehi-Pourmehr, Sona Tayebi, Nooriyeh DalirAkbari, Amir Ghabousian, Fateme Tahmasbi, Fatemeh Rahmati, Amirreza Naseri, Reyhaneh Hajebrahimi, Robab Mehdipour, Mahdi Hemmati-Ghavshough, Ali Mostafaei & Sakineh Hajebrahimi
Supplemental material, sj-docx-1-sjs-10.1177_14574969221145774 for Management of urolithiasis in pregnancy: A systematic review and meta-analysis by Hanieh Salehi-Pourmehr, Sona Tayebi, Nooriyeh DalirAkbari, Amir Ghabousian, Fateme Tahmasbi, Fatemeh Rahmati, Amirreza Naseri, Reyhaneh Hajebrahimi, Robab Mehdipour, Mahdi Hemmati-Ghavshough, Ali Mostafaei and Sakineh Hajebrahimi in Scandinavian Journal of Surgery

sj-docx-1-smo-10.1177_20503121221118712 – Supplemental material for Prevalence of physical activity using validated tools among adults during the COVID-19 pandemic in the Eastern Mediterranean region: A systematic review and meta-analysis

Ahmed Hassan Albelbeisi, Morteza Arab-Zozani, Marjan Khabiri Nemati, Khalil Mostafa Shaqfa & Edris Kakemam
Supplemental material, sj-docx-1-smo-10.1177_20503121221118712 for Prevalence of physical activity using validated tools among adults during the COVID-19 pandemic in the Eastern Mediterranean region: A systematic review and meta-analysis by Ahmed Hassan Albelbeisi, Morteza Arab-Zozani, Marjan Khabiri Nemati, Khalil Mostafa Shaqfa and Edris Kakemam in SAGE Open Medicine

Additional file 2 of Effect of implementing a birth plan on maternal and neonatal outcomes: a randomized controlled trial

Parivash Ahmadpour, Sanaz Moosavi, Sakineh Mohammad-Alizadeh-Charandabi, Shayesteh Jahanfar & Mojgan Mirghafourvand
Additional file 2.

Additional file 2 of Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019

Malihe Rezaee, Zahra Esfahani, Seyed Aria Nejadghaderi, Mohsen Abbasi-Kangevari, Sahar Saeedi Moghaddam, Ali Ghanbari, Azin Ghamari, Ali Golestani, Elmira Foroutan Mehr, Ameneh Kazemi, Rosa Haghshenas, Mahsa Moradi, Farzad Kompani, Negar Rezaei & Bagher Larijani
Additional file 2. Rate of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) attributable to lead exposure in 21 countries of North Africa and Middle East region in 1990 and 2019, by sex and age.

Additional file 2 of Design and synthesis of novel ureido and thioureido conjugated hydrazone derivatives with potent anticancer activity

Nasrin Nassiri Koopaei, Mehrasa Shademani, Nasrin Shirzad Yazdi, Raheleh Tahmasvand, Mina Dehbid, Mansur Nassiri Koopaei, Homa Azizian, Zahra Mousavi, Ali Almasirad & Mona Salimi
Additional file 2: Table S1. Cytotoxicity screening (%) for compounds 4a–4i following treatment at 10 μM for 72 h, towards human cancer cell lines. Table S2. IC50 values for cytotoxic activity of doxorubicin towards cancer cells at 72 h.

Additional file 4 of The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990–2019

Hamidreza Feizi, Mahasti Alizadeh, Seyed Aria Nejadghaderi, Maryam Noori, Mark J. M. Sullman, Javad Ahmadian Heris, Ali-Asghar Kolahi, Gary S. Collins & Saeid Safiri
Additional file 4: Table S4. DALYs due to chronic obstructive pulmonary disease in 1990 and 2019 for both sexes and percentage change in age-standardised rates (ASRs) per 100,000 in the Middle East and North Africa region (generated from data available from http://ghdx.healthdata.org/gbd-results-tool ).

Additional file 1 of Psychometric properties of public trust in Covid-19 control and prevention policies questionnaire

Riaz Alaei Kalajahi, Mohammad Saadati, Saber Azami Aghdash, Ramin Rezapour, Mehdi Nouri, Naser Derakhshani & Koustuv Dalal
Supplementary Material 1

Registration Year

  • 2023
    4
  • 2022
    52

Resource Types

  • Text
    56

Affiliations

  • Tabriz University of Medical Sciences
    56
  • Tehran University of Medical Sciences
    30
  • Iran University of Medical Sciences
    24
  • Universal Scientific Education and Research Network
    22
  • Shahid Beheshti University of Medical Sciences
    22
  • University of Nicosia
    18
  • NIHR Oxford Musculoskeletal Biomedical Research Centre
    16
  • Oxford University Hospitals NHS Trust
    16
  • University of Oxford
    16
  • University of Rochester
    8